Clinical evaluation and validation of laboratory methods for the diagnosis of Bordetella pertussis infection: Culture, polymerase chain reaction (PCR) and anti-pertussis toxin IgG serology (IgG-PT)
Authors:
Open Access
- 13 April 2018
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 13 (4) , e0195979
Abstract
The appropriate use of clinically accurate diagnostic tests is essential for the detection of pertussis, a poorly controlled vaccine-preventable disease. The purpose of this study was to estimate the sensitivity and specificity of different diagnostic criteria including culture, multi-target polymerase chain reaction (PCR), anti-pertussis toxin IgG (IgG-PT) serology, and the use of a clinical case definition. An additional objective was to describe the optimal timing of specimen collection for the various tests. Clinical specimens were collected from patients with cough illness at seven locations across the United States between 2007 and 2011. Nasopharyngeal and blood specimens were collected from each patient during the enrollment visit. Patients who had been coughing for ≤ 2 weeks were asked to return in 2–4 weeks for collection of a second, convalescent blood specimen. Sensitivity and specificity of each diagnostic test were estimated using three methods—pertussis culture as the “gold standard,” composite reference standard analysis (CRS), and latent class analysis (LCA). Overall, 868 patients were enrolled and 13.6% were B. pertussis positive by at least one diagnostic test. In a sample of 545 participants with non-missing data on all four diagnostic criteria, culture was 64.0% sensitive, PCR was 90.6% sensitive, and both were 100% specific by LCA. CRS and LCA methods increased the sensitivity estimates for convalescent serology and the clinical case definition over the culture-based estimates. Culture and PCR were most sensitive when performed during the first two weeks of cough; serology was optimally sensitive after the second week of cough. Timing of specimen collection in relation to onset of illness should be considered when ordering diagnostic tests for pertussis. Consideration should be given to including IgG-PT serology as a confirmatory test in the Council of State and Territorial Epidemiologists (CSTE) case definition for pertussis.Keywords
This publication has 29 references indexed in Scilit:
- Does Tetanus-Diphtheria-Acellular Pertussis Vaccination Interfere with Serodiagnosis of Pertussis Infection?Clinical and Vaccine Immunology, 2012
- Aerosolized Vaccine as an Unexpected Source of False-Positive Bordetella pertussis PCR ResultsJournal of Clinical Microbiology, 2012
- Novel Multitarget Real-Time PCR Assay for Rapid Detection of Bordetella Species in Clinical SpecimensJournal of Clinical Microbiology, 2011
- Performance of Commercial Enzyme-Linked Immunosorbent Assays for Detection of Antibodies to Bordetella pertussisJournal of Clinical Microbiology, 2010
- What to do and what not to do in serological diagnosis of pertussis: recommendations from EU reference laboratoriesEuropean Journal of Clinical Microbiology & Infectious Diseases, 2010
- Development and Analytical Validation of an Immunoassay for Quantifying Serum Anti-Pertussis Toxin Antibodies Resulting from Bordetella pertussis InfectionClinical and Vaccine Immunology, 2009
- Development and evaluation of dual-target real-time polymerase chain reaction assays to detect Bordetella spp.Diagnostic Microbiology and Infectious Disease, 2008
- Utility of Composite Reference Standards and Latent Class Analysis in Evaluating the Clinical Accuracy of Diagnostic Tests for PertussisClinical and Vaccine Immunology, 2008
- Establishment of Diagnostic Cutoff Points for Levels of Serum Antibodies to Pertussis Toxin, Filamentous Hemagglutinin, and Fimbriae in Adolescents and Adults in the United StatesClinical and Vaccine Immunology, 2004
- The Increasing Incidence of Pertussis in Massachusetts Adolescents and Adults, 1989–1998The Journal of Infectious Diseases, 2000